The content on this site is intended for healthcare professionals only
Dr Luis Raez speaks to ecancer about immunotherapy in lung cancer. Initially, he discusses the CheckMate A16 trial and the importance of its results.
Dr Raez then explains the IMPower10 study and its significance in the immunotherapy setting. He also discusses the PACIFIC and CheckMate 9LA trials.
Watch the meeting in full by following the links below:
Concurrent thoracic radiotherapy plus chemo-ICI shows no overall survival benefit in ES-SCLC
WCLC 2025: Latest in EGFR positive NSCLC
Key insights from lung cancer research at ASCO 2025
ELCC 2025: Latest in EGFR positive NSCLC
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Treating relapsed multiple myeloma outside of use of T-cell redirected therapies
Guiding transplant decisions in multiple myeloma with MRD
ESMO and WCLC: Latest developments in EGFR mutated NSCLC
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
